COMMUNIQUÉS West-GlobeNewswire

Solid Biosciences Announces Pricing of Initial Public Offering
26/01/2018
CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (NASDAQ: SLDB ) today announced the pricing of its initial public offering of 7,812,500 shares of its common stock at a price to the public of $ [...]
Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares
26/01/2018
DUBLIN, Ireland and TREVOSE, Pa., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP ) (the “Company”) today announced that it has priced its previously announced underwritten public offering of [...]
Kraig Biocraft Laboratories Expands Material Performance Testing Procedures
25/01/2018
ANN ARBOR, Mich., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company has recently [...]
Anthera Receives Positive Nasdaq Listing Determination
25/01/2018
HAYWARD, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH ) today announced that on January 24, 2018, Anthera received formal notice that the Nasdaq Hearings Panel granted Anthera’s [...]
Five Prime Therapeutics Announces $25 Million Payment by Bristol-Myers Squibb for Cabiralizumab Development Milestone
25/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq: FPRX ), a biotechnology company discovering and developing innovative immuno-oncology protein therapeutics, today [...]
Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares
25/01/2018
WALTHAM, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX ), a leader in the development of restorative cell therapies, today announced the closing of its previously announced [...]
Fluidigm to Report Q4 and Full Year 2017 Financial Results
25/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced that it will report fourth quarter and full year 2017 financial results on Thursday, February 8, 2018, [...]
Intuitive Surgical Announces Fourth Quarter Earnings
25/01/2018
SUNNYVALE, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (NASDAQ: ISRG ), a global technology leader in robotic-assisted, minimally invasive surgery, today announced financial results for the [...]
Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
25/01/2018
SANTA BARBARA, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today announced that on January 19, 2018, the Compensation Committee of [...]
Adverum Biotechnologies and Editas Medicine Extend Research Collaboration
25/01/2018
MENLO PARK, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM ), a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases, announced [...]
Adherium Names Tim Houchin Vice President of Sales
25/01/2018
SAN MATEO, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced Tim Houchin as Vice President of Sales. “Tim [...]
New Study Identifies Successful Approaches to Antimicrobial Stewardship Programs in U.S. Hospitals
25/01/2018
OAKBROOK TERRACE, Ill., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Misuse of antibiotics can lead to antibiotic resistance, accounting for more than two million infections and 23,000 deaths annually in the United States. 1 To [...]
IBA SA : IBA - TRANSPARENCY NOTIFICATION
25/01/2018
IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, January 25, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that [...]
IBA SA : IBA - NOTIFICATION DE TRANSPARENCE
25/01/2018
IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 25 janvier 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]
Expert Panel Brings New Approach to Challenges of Aging in Rural America
25/01/2018
WASHINGTON, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Academic, business, and healthcare leaders from across the country gathered today at the Newseum in Washington, D.C. to bring focus to a new approach to solving the [...]
OSE Immunotherapeutics Receives Notice of Allowance for New Patent by U.S. Patent and Trademark Office that Further Strengthens Intellectual Property Portfolio Around Tedopi® in Immuno-Oncology Applications
25/01/2018
NANTES, France, Jan. 25, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics (ISIN:FR0012127173) (Mnémo:OSE), today announces that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for [...]
ProMIS Neurosciences to Present at Upcoming Investor Conferences
25/01/2018
TORONTO and CAMBRIDGE, Mass., Jan. 25, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc., a biotechnology company focused on the discovery and development of precision treatments for neurodegenerative diseases, today [...]
Exagen Diagnostics announces collaboration with GSK to drive greater awareness about challenges facing lupus diagnosis and management
25/01/2018
ALBUQUERQUE, NM and SAN DIEGO, CA, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics, Inc. today announced a first-of-its kind collaboration with GSK to raise awareness of its laboratory tests, which facilitate early [...]
Nextech Highlights NexCloud for Medical Spas at the American Med Spa Association Show
25/01/2018
TAMPA, Fla., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of health care technology solutions for specialty physician practices, will present its leading aesthetic medicine cloud technology for [...]

Pages